While the business of Biotage continues to perform well, following consultation with the Board Tomas Blomquist will leave his role as CEO & President of Biotage AB with immediate effect. The Chairman of the Board, Torben Jørgensen, has been appointed by the Board of Directors as interim CEO while the process of recruiting a new […]
ROCKVILLE, Md. — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioprocessing applications, is pleased to confirm the appointment of Maher Masoud as President and Chief Executive Officer of MaxCyte effective as of January 1, […]
Penny James, BioPharmaceuticals R&D Chief Operating Officer at AstraZeneca, Brings Three Decades of Expertise to Strengthen My Green Lab’s Commitment to Sustainable Science NORTHAMPTON, MA — My Green Lab, the world’s leading nonprofit organization dedicated to improving the sustainability of scientific research, is proud to announce the appointment of Penny James to its Board of […]
InSphero, the global leader in 3D in vitro technology for drug safety and efficacy testing, is proud to announce the appointment of Paul Clémençon, MBA as the new Chief Business Officer (CBO), further strengthening its Executive team. Zürich, Switzerland — InSphero, the global leader in 3D in vitro technology for drug safety and efficacy testing, is proud to announce […]
COLUMBUS, Ohio — Mettler-Toledo International Inc. (NYSE: MTD) announced today that Robert F. Spoerry will retire and not stand for re-election to the Board of Directors at the annual meeting of shareholders on May 9th, 2024. Mr. Spoerry served Mettler-Toledo for 40 years, including as the CEO from 1993 until 2007, and Chair of the […]
Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions Cambridge, UK: Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, is pleased to announce the appointment of Dr. Graeme Daniels, PhD, as the new Vice President of Sales and Marketing. In his role […]
Doug Doerfler, President and CEO, to Retire Effective December 31, 2023; will continue to serve as an advisor to MaxCyte Maher Masoud, EVP, Head of Global Business Development and Chief Counsel, to Succeed Mr. Doerfler as President and CEO, Effective January 1, 2024 MaxCyte is reiterating 2023 expected core business revenue of $28-30 million, and the Company now expects to […]
MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that David Botstein, Ph.D., a member of PacBio’s Board of Directors, has retired from his position effective December 7, 2023. “I would like to thank David for his dedication to PacBio since he joined the Board in 2012,” said Christian Henry, […]
WALTHAM, Mass. — NanoMosaic, the trailblazing company in the realm of true multi-omic analysis, announces a strategic shift in its leadership team with the appointment of John Boyce as Executive Chairman, Philippe Mourere as Chief Executive Officer, and Joe Wilkinson as President and Chief Operating Officer. Philippe Mourere, the company’s newly appointed CEO, brings extensive experience in the protein and nucleic acid […]
Transformative New Operating Model to Feature Two Complementary Business Segments Aligned to Customer Needs: Laboratory Solutions and Bioscience Production Company Launches Cost Optimization Initiative to Deliver $300M in Run Rate Savings by the end of 2026 Reaffirms Fiscal Year 2023 Guidance RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
